Evaluate gives you the understanding and time you need to drive better decisions.

When you partner with Evaluate, our constantly expanding solutions and transparent methodologies and datasets are instantly at your disposal, along with expert, personalised support.

Evaluate gives you the time and confidence to turn understanding into insight, and insight into action.

How we can help you
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.
Market Reports
Market Reports
Thought Leadership

Read our wide range of complimentary market reports covering sector performance and valuation, market trends and global forecasts, including our annual EvaluatePharma World Preview. 

More
EvaluatePharma
OUR PRODUCTS
EvaluatePharma

Get a global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2024 and the first single view of the risk and reward of the R&D landscape from EvaluatePharma Vision.

More
custom solutions
OUR SERVICES
Custom Solutions

Improve your strategic decision-making with customised solutions that draw on our team of industry experts and trusted commercial intelligence. 

More
Kickstarting ideas
 Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Thumbnail

Roxadustat passes Alps test but has bigger mountains to climb

Fibrogen’s roxadustat has its first European win from the Alps trial, but the most important event is still to come.

Thumbnail

Attention deficit disorder focus turns to side effects

Limiting abuse and reducing risks are the differentiating factors for projects from Kempharm and Supernus.
Thumbnail

Voxeleron looks into ocular disease prognosis

Thumbnail

Viking sails on favourable Nash winds

Thumbnail

Novo casts its net wider but shrinks in the process

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up